Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Clinical trial NCT02323906 · TERMINATED
Trial details
- NCT number
- NCT02323906
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-16
- Primary completion
- 2016-12-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.